Activation of c-MET induces a stem-like phenotype in human prostate cancer
about
Met in urological cancersc-Met signaling in the development of tumorigenesis and chemoresistance: potential applications in pancreatic cancerCrosstalk between nuclear MET and SOX9/β-catenin correlates with castration-resistant prostate cancerA minimal connected network of transcription factors regulated in human tumors and its application to the quest for universal cancer biomarkersGD3 synthase regulates epithelial-mesenchymal transition and metastasis in breast cancer.Inhibition of mesothelioma cancer stem-like cells with adenovirus-mediated NK4 gene therapy.Emerging targeted therapies for castration-resistant prostate cancer.Heteronemin Is a Novel c-Met/STAT3 Inhibitor Against Advanced Prostate Cancer Cells.Absent and abundant MET immunoreactivity is associated with poor prognosis of patients with oral and oropharyngeal squamous cell carcinoma.Hypoxia, notch signalling, and prostate cancer.Dynamic Interactions Between Cancer Stem Cells And Their Stromal Partners.RANK- and c-Met-mediated signal network promotes prostate cancer metastatic colonization.Tumor-suppressive activity of Lunatic Fringe in prostate through differential modulation of Notch receptor activation.Activation of LINE-1 Retrotransposon Increases the Risk of Epithelial-Mesenchymal Transition and Metastasis in Epithelial Cancer.Priming cancer cells for drug resistance: role of the fibroblast niche.Targeting Apoptotic Activity Against Prostate Cancer Stem Cells.PIM1 kinase as a promise of targeted therapy in prostate cancer stem cellsSOX9 drives WNT pathway activation in prostate cancer.Hepatocyte Growth Factor, a Key Tumor-Promoting Factor in the Tumor Microenvironment.MiR-1247-5p is overexpressed in castration resistant prostate cancer and targets MYCBP2.Long-term efficiency of mesenchymal stromal cell-mediated CD-MSC/5FC therapy in human melanoma xenograft model.MET: roles in epithelial-mesenchymal transition and cancer stemness.Prostate cancer stem-like cells/cancer-initiating cells have an autocrine system of hepatocyte growth factor.Semaphorin 3 C drives epithelial-to-mesenchymal transition, invasiveness, and stem-like characteristics in prostate cells.MET expression during prostate cancer progression.B4 androgen ablation: attacking the prostate cancer stem cell.Study of the interaction among Notch pathway receptors, correlation with stemness, as well as their interaction with CD44, dipeptidyl peptidase-IV, hepatocyte growth factor receptor and the SETMAR transferase, in colon cancer stem cells.Physiological Signaling and Structure of the HGF Receptor MET.Validation of stem cell markers in clinical prostate cancer: α6-integrin is predictive for non-aggressive disease.Combined CD44, c-MET, and EGFR expression in p16-positive and p16-negative head and neck squamous cell carcinomas.
P2860
Q26864988-84A35F0F-F432-4FA3-885E-4D89CA3EB3A8Q33886974-2B946708-CAC2-469B-9FD3-7928054DADA3Q34265065-CAD757E8-017A-4BE9-B581-4B38C2EBEC64Q34326409-7BB693BF-99D0-4342-89FB-5AFB5BA98187Q35072671-1D6E3591-6724-4B9A-9DB0-48CB0C61C4DCQ35598236-67BC4685-4A22-4D23-86BD-D0CC0A759393Q35999255-9E54B2BB-A90B-4C56-A8D3-97FA3608EB8CQ36077939-BE095BF1-5734-4878-BD76-72573D995FC7Q37022410-E1A8FF18-6204-4455-A560-E05372F1B710Q37589392-42AFBCAF-AC4E-4E92-A29A-0BF1B9DED106Q37641700-9C9FF104-6208-4AA1-8826-A9BB45450B2EQ37648868-362D66D9-4DAC-46A7-B614-AEB5B4B6D89FQ37689604-FB2445E7-6E64-404A-BAF4-1F6198706769Q37741550-EBC8FD53-09AE-4E06-8928-2471FF19E632Q38232067-627FB8F4-41F6-4181-8149-6F9B19557DE9Q38652074-23CBC140-242D-48D5-9F9C-0DC6171165C0Q38719202-8E1E6EF9-3B4E-403E-BCD4-05E3BAEF9BDDQ38780862-37E5D65F-F417-4B50-970B-F955F2AB31FAQ38831784-499F87C6-CE49-4CD0-AE79-CF834DAA724EQ38904609-D6C83816-CDFF-4327-B95F-C6D7F66A3BCAQ38972307-E738DC30-B331-4C19-8BDB-F9EE9D10B156Q39121333-EE8A44C8-E5A2-4553-8BCC-38CCE5CD5642Q39210179-16CB1C8E-FD95-4A66-8030-D86526DED95DQ41127576-C0F0C19C-255F-41AE-B93E-CA5B1E8B046CQ41418443-F4832D58-946B-4F89-ADC2-19695DDFC91BQ43122639-99322637-51B3-4966-A395-5CF22C747C93Q47731836-81FA377C-2CDB-476B-954E-404C993478A9Q50985118-9858FF7F-70D9-48DB-9B23-8BB3AE2111D4Q54387640-7F10A450-0557-4EE6-BBFB-FB2732F4CAA5Q54601530-D77D47A9-5809-4F55-B8A8-602F87A4A67D
P2860
Activation of c-MET induces a stem-like phenotype in human prostate cancer
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Activation of c-MET induces a stem-like phenotype in human prostate cancer
@ast
Activation of c-MET induces a stem-like phenotype in human prostate cancer
@en
Activation of c-MET induces a stem-like phenotype in human prostate cancer
@nl
type
label
Activation of c-MET induces a stem-like phenotype in human prostate cancer
@ast
Activation of c-MET induces a stem-like phenotype in human prostate cancer
@en
Activation of c-MET induces a stem-like phenotype in human prostate cancer
@nl
prefLabel
Activation of c-MET induces a stem-like phenotype in human prostate cancer
@ast
Activation of c-MET induces a stem-like phenotype in human prostate cancer
@en
Activation of c-MET induces a stem-like phenotype in human prostate cancer
@nl
P2093
P2860
P1433
P1476
Activation of c-MET induces a stem-like phenotype in human prostate cancer
@en
P2093
Andrea Sacchetti
Corrina M A de Ridder
Geert J L H van Leenders
Guido Jenster
Kees J Vissers
Rajesh Sookhlall
Suzanne Reneman
Wilma J Teubel
Wytske van Weerden
P2860
P304
P356
10.1371/JOURNAL.PONE.0026753
P407
P577
2011-11-14T00:00:00Z